Dopamine-regulated microRNA miR-181a controls GluA2 surface expression in hippocampal neurons

Molecular and Cellular Biology

Volumn 32, Issue 3, 2012, Pages 619-632

  Saba, Reuben ^a,d   Störchel, Peter H ^a,b   Aksoy Aksel, Ayla ^b   Kepura, Frauke ^b   Lippi, Giordano ^c,e   Plant, Tim D ^b   Schratt, Gerhard M ^a,b  

^a UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

^b PHILIPPS UNIVERSITY MARBURG   (Germany)

^c UNIVERSITY OF LEICESTER   (United Kingdom)

^d PUBLIC HEALTH AGENCY OF CANADA   (Canada)

^e UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPA RECEPTOR; AMPHETAMINE; COCAINE; DOPAMINE; MESSENGER RNA; MICRORNA; MICRORNA 181A; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG ABUSE; DRUG DEPENDENCE; EMBRYO; EXCITATORY POSTSYNAPTIC POTENTIAL; HIPPOCAMPUS; IMMUNOHISTOCHEMISTRY; MICROARRAY ANALYSIS; MOUSE; NERVE CELL PLASTICITY; NONHUMAN; NUCLEUS ACCUMBENS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; RNA ISOLATION; SIGNAL TRANSDUCTION; TREATMENT RESPONSE; UPREGULATION;

ANIMALS; COCAINE; DOPAMINE; DOPAMINE UPTAKE INHIBITORS; EXCITATORY POSTSYNAPTIC POTENTIALS; HIPPOCAMPUS; MALE; METHAMPHETAMINE; MICE; MICRORNAS; NEURONAL PLASTICITY; NEURONS; NUCLEUS ACCUMBENS; RATS; RECEPTORS, AMPA;

MAMMALIA;

EID: 84856781416     PISSN: 02707306     EISSN: 10985549     Source Type: Journal    
DOI: 10.1128/MCB.05896-11     Document Type: Article

References (67)

1. Argilli E, Sibley DR, Malenka RC, England PM, Bonci A. 2008. Mechanism and time course of cocaine-induced long-term potentiation in the ventral tegmental area. J. Neurosci. 28:9092-9100.
2. Bartel DP. 2004. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116:281-297.
3. Bellone C, Luscher C. 2006. Cocaine triggered AMPA receptor redistribution is reversed in vivo by mGluR-dependent long-term depression. Nat. Neurosci. 9:636-641.
4. Beveridge NJ, et al. 2008. Dysregulation of miRNA 181b in the temporal cortex in schizophrenia. Hum. Mol. Genet. 17:1156-1168.
5. Bolstad BM, Irizarry RA, Astrand M, Speed TP. 2003. A comparison of normalization methods for high density oligonucleotide array data based on variance and bias. Bioinformatics 19:185-193.
6. Burnashev N, Monyer H, Seeburg PH, Sakmann B. 1992. Divalent ion permeability of AMPA receptor channels is dominated by the edited form of a single subunit. Neuron 8:189-198.
7. Bussey KJ, et al. 2003. MatchMiner: a tool for batch navigation among gene and gene product identifiers. Genome Biol. 4:R27.
8. Chandrasekar V, Dreyer JL. 2009. microRNAs miR-124, let-7d and miR-181a regulate cocaine-induced plasticity. Mol. Cell. Neurosci. 42:350-362.
9. Chandrasekar V, Dreyer JL. 2011. Regulation of MiR-124, Let-7d, and MiR-181a in the accumbens affects the expression, extinction, and reinstatement of cocaine-induced conditioned place preference. Neuropsychopharmacology 36:1149-1164.
10. Chen CZ, Li L, Lodish HF, Bartel DP. 2004. MicroRNAs modulate hematopoietic lineage differentiation. Science 303:83-86.
11. Conrad KL, et al. 2008. Formation of accumbens GluR2-lacking AMPA receptors mediates incubation of cocaine craving. Nature 454:118-121.
12. Cougot N, et al. 2008. Dendrites of mammalian neurons contain specialized P-body-like structures that respond to neuronal activation. J. Neurosci. 28:13793-13804.
13. Di Chiara G. 2002. Nucleus accumbens shell and core dopamine: differential role in behavior and addiction. Behav. Brain Res. 137:75-114.
14. Fiore R, et al. 2009. Mef2-mediated transcription of the miR379-410 cluster regulates activity-dependent dendritogenesis by fine-tuning Pumilio2 protein levels. EMBO J. 28:697-710.
15. Gao C, Sun X, Wolf ME. 2006. Activation of D1 dopamine receptors increases surface expression of AMPA receptors and facilitates their synaptic incorporation in cultured hippocampal neurons. J. Neurochem. 98: 1664-1677.
16. Grimson A, et al. 2007. MicroRNA targeting specificity in mammals: determinants beyond seed pairing. Mol. Cell 27:91-105.
17. He Y, Yang C, Kirkmire CM, Wang ZJ. 2010. Regulation of opioid tolerance by let-7 family microRNA targeting the mu opioid receptor. J. Neurosci. 30:10251-10258.
18. Hollander JA, et al. 2010. Striatal microRNA controls cocaine intake through CREB signalling. Nature 466:197-202.
19. Huang W, Li MD. 2009. Differential allelic expression of dopamine D1 receptor gene (DRD1) is modulated by microRNA miR-504. Biol. Psychiatry 65:702-705.
20. Huang W, Li MD. 2009. Nicotine modulates expression of miR-140*, which targets the 3=-untranslated region of dynamin 1 gene (Dnm1). Int. J. Neuropsychopharmacol. 12:537-546.
21. Huang YH, et al. 2009. In vivo cocaine experience generates silent synapses. Neuron 63:40-47.
22. Im HI, Hollander JA, Bali P, Kenny PJ. 2010. MeCP2 controls BDNF expression and cocaine intake through homeostatic interactions with microRNA-212. Nat. Neurosci. 13:1120-1127.
23. Job C, Eberwine J. 2001. Localization and translation of mRNA in dendrites and axons. Nat. Rev. Neurosci. 2:889-898.
24. John B, et al. 2004. Human MicroRNA targets. PLoS Biol. 2:e363.
25. Ju W, et al. 2004. Activity-dependent regulation of dendritic synthesis and trafficking of AMPA receptors. Nat. Neurosci. 7:244-253.
26. Kacharmina JE, Job C, Crino P, Eberwine J. 2000. Stimulation of glutamate receptor protein synthesis and membrane insertion within isolated neuronal dendrites. Proc. Natl. Acad. Sci. U. S. A. 97:11545-11550.
27. Karr J, et al. 2009. Regulation of glutamate receptor subunit availability by microRNAs. J. Cell Biol. 185:685-697.
28. Kauer JA, Malenka RC. 2007. Synaptic plasticity and addiction. Nat. Rev. Neurosci. 8:844-858.
29. Krek A, et al. 2005. Combinatorial microRNA target predictions. Nat. Genet. 37:495-500.
30. Krichevsky AM, King KS, Donahue CP, Khrapko K, Kosik KS. 2003. A microRNA array reveals extensive regulation of microRNAs during brain development. RNA 9:1274 -1281.
31. Kye MJ, et al. 2007. Somatodendritic microRNAs identified by laser capture and multiplex RT-PCR. RNA 13:1224-1234.
32. Le Moal M, Simon H. 1991. Mesocorticolimbic dopaminergic network: functional and regulatory roles. Physiol. Rev. 71:155-234.
33. Lippi G, et al. 2011. Targeting of the Arpc3 actin nucleation factor by microRNA-29a/b regulates dendritic spine morphology. J. Cell Biol. 194: 889-904.
34. Livak KJ, Schmittgen TD. 2001. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 25:402-408.
35. Lugli G, Larson J, Martone ME, Jones Y, Smalheiser NR. 2005. Dicer and eIF2c are enriched at postsynaptic densities in adult mouse brain and are modified by neuronal activity in a calpain-dependent manner. J. Neurochem. 94:896-905.
36. Lugli G, Torvik VI, Larson J, Smalheiser NR. 2008. Expression of microRNAs and their precursors in synaptic fractions of adult mouse forebrain. J. Neurochem. 106:650-661.
37. Luscher C, et al. 1999. Role of AMPA receptor cycling in synaptic transmission and plasticity. Neuron 24:649-658.
38. Malenka RC, Nicoll RA. 1999. Long-term potentiation-a decade of progress? Science 285:1870-1874.
39. Mameli M, Bellone C, Brown MT, Luscher C. 2011. Cocaine inverts rules for synaptic plasticity of glutamate transmission in the ventral tegmental area. Nat. Neurosci. 14:414-416.
40. Man HY. 2011. GluA2-lacking, calcium-permeable AMPA receptors- inducers of plasticity? Curr. Opin. Neurobiol. 21:291-298.
41. Miranda RC, et al. 2010. MicroRNAs: master regulators of ethanol abuse and toxicity? Alcohol. Clin. Exp. Res. 34:575-587.
42. Nestler EJ. 2001. Molecular neurobiology of addiction. Am. J. Addict. 10:201-217.
43. Passafaro M, Nakagawa T, Sala C, Sheng M. 2003. Induction of dendritic spines by an extracellular domain of AMPA receptor subunit GluR2. Nature 424:677-681.
44. Pietrzykowski AZ, et al. 2008. Posttranscriptional regulation of BK channel splice variant stability by miR-9 underlies neuroadaptation to alcohol. Neuron 59:274-287.
45. Rao A, Steward O. 1991. Evidence that protein constituents of postsynaptic membrane specializations are locally synthesized: analysis of proteins synthesized within synaptosomes. J. Neurosci. 11:2881-2895.
46. Robinson TE, Kolb B. 2004. Structural plasticity associated with exposure to drugs of abuse. Neuropharmacology 47(Suppl. 1):33-46.
47. Schaefer A, et al. 2010. Argonaute 2 in dopamine 2 receptor-expressing neurons regulates cocaine addiction. J. Exp. Med. 207:1843-1851.
48. Schratt G. 2009. microRNAs at the synapse. Nat. Rev. Neurosci. 10:842-849.
49. Schratt GM, Nigh EA, Chen WG, Hu L, Greenberg ME. 2004. BDNF regulates the translation of a select group of mRNAs by a mammalian target of rapamycin-phosphatidylinositol 3-kinase-dependent pathway during neuronal development. J. Neurosci. 24:7366-7377.
50. Schratt GM, et al. 2006. A brain-specific microRNA regulates dendritic spine development. Nature 439:283-289.
51. Schuman EM, Dynes JL, Steward O. 2006. Synaptic regulation of translation of dendritic mRNAs. J. Neurosci. 26:7143-7146.
52. Sibley DR, Leff SE, Creese I. 1982. Interactions of novel dopaminergic ligands with D-1 and D-2 dopamine receptors. Life Sci. 31:637-645.
53. Siegel G, et al. 2009. A functional screen implicates microRNA-138-dependent regulation of the depalmitoylation enzyme APT1 in dendritic spine morphogenesis. Nat. Cell Biol. 11:705-716.
54. Smith WB, Starck SR, Roberts RW, Schuman EM. 2005. Dopaminergic stimulation of local protein synthesis enhances surface expression of GluR1 and synaptic transmission in hippocampal neurons. Neuron 45: 765-779.
55. Sprengel R, et al. 2001. Glutamate receptor channel signatures. Trends Pharmacol. Sci. 22:7-10.
56. Steward O, Schuman EM. 2001. Protein synthesis at synaptic sites on dendrites. Annu. Rev. Neurosci. 24:299-325.
57. Sun X, Wolf ME. 2009. Nucleus accumbens neurons exhibit synaptic scaling that is occluded by repeated dopamine pre-exposure. Eur. J. Neurosci. 30:539-550.
58. Sutton MA, Schuman EM. 2005. Local translational control in dendrites and its role in long-term synaptic plasticity. J. Neurobiol. 64:116-131.
59. Sutton MA, Wall NR, Aakalu GN, Schuman EM. 2004. Regulation of dendritic protein synthesis by miniature synaptic events. Science 304: 1979-1983.
60. Swanson GT, Kamboj SK, Cull-Candy SG. 1997. Single-channel properties of recombinant AMPA receptors depend on RNA editing, splice variation, and subunit composition. J. Neurosci. 17:58-69.
61. Tada T, Sheng M. 2006. Molecular mechanisms of dendritic spine morphogenesis. Curr. Opin. Neurobiol. 16:95-101.
62. Tang J, Dani JA. 2009. Dopamine enables in vivo synaptic plasticity associated with the addictive drug nicotine. Neuron. 63:673-682.
63. Tusher VG, Tibshirani R, Chu G. 2001. Significance analysis of microarrays applied to the ionizing radiation response. Proc. Natl. Acad. Sci. U. S. A. 98:5116-5121.
64. Wolf ME. 2010. The Bermuda Triangle of cocaine-induced neuroadaptations. Trends Neurosci. 33:391-398.
65. Wolf ME, Mangiavacchi S, Sun X. 2003. Mechanisms by which dopamine receptors may influence synaptic plasticity. Ann. N. Y. Acad. Sci. 1003:241-249.
66. Zhou R, et al. 2009. Evidence for selective microRNAs and their effectors as common long-term targets for the actions of mood stabilizers. Neuropsychopharmacology 34:1395-1405.
67. Ziviani E, et al. 2011. Ryanodine receptor-2 upregulation and nicotinemediated plasticity. EMBO J. 30:194-204